InMed Pharmaceuticals's ticker is IMLFF and the CUSIP is 457637106. A total of 1 filers reported holding InMed Pharmaceuticals in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | – | 72 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlphaMark Advisors, LLC | 72 | $0 | 0.00% |